Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

Lawmakers on Capitol Hill were briefed by drug experts about emerging illicit drug threats in the United States and what to ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

A group of scientists from the University of Auckland recently studied whether a cancer drug called alpelisib could also slow down aging. Alpelisib is currently used to treat certain types of cancer, ...

The total shutdown of debate and conversation has eroded trust in science more than most people believed possible.

The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...

Following a trial that revolved around the testimony of one key witness who described himself as “a liar and a thief,” jurors are now tasked with determining his credibility. In his instructions ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...